摘要
目的探讨孕三烯酮治疗子宫内膜异位症的疗效观察。方法A组(30例)患者给予妇宁片40mg/d,B组(31例)患者给予孕三烯酮2.5mg,每周两次,疗程共6个月,观察治疗前后症状、体征、病灶大小及副反应。结果A组总主观症状评分于治疗3个月及6个月下降61%及84%,B组下降37%,90%(P<0.05),A组病灶分别于3个月,6个月缩小了37%,41%,B组分别缩小了46%,54%(P<0.05)孕三烯酮的不良反应小。结论孕三烯酮和妇宁片能有效治疗子宫内膜异位症,但孕三烯酮疗效更确切,不良反应小,使用方便。
Objective To study the efficacy and safety of gestrinone in the treatment of endometriosis. Methods Sixty- one women with endometriosis were randomized into two groups, group A（n = 30） were treated with metroxy progesterone（40mg, qd. po） and group B （n = 31 ） were treated with gestrinone （2.5mg. 2/W. po）for 6 months. Results Total subjective symptom scores of group A decreased 61% and 84% at 3 months and 6months respectively, of group B, decreased 37 % and 90% in total respectively. According to reductions in endometrotic foei, the results of group B （46% at 3months, 54% at 6 months） were significantly higher than group A （37% and 41% respectively） （ P 〈 0.05）. The side effects of group A were severer than group B. Conclusion Gestrinone is more effective and convenience in treatment of endometriosis.
出处
《中原医刊》
2006年第13期28-29,共2页
Central Plains Medical Journal
